The chance for simultaneous use of antitubercular agent rifampicin and oral hypoglycemic drugs is increasing. Rifampicin is a classic inducer of drug metabolizing enzyme and transporter for clinical research. 作为一种常用的抗结核药物,利福平与口服降糖药的合用机会也随之增多。另外,利福平作为一种经典的药物代谢酶和转运体诱导剂广泛应用于临床试验。